How ClearPath Improves Nasal Patency
If you’ve ever felt like you can’t get a full breath through your nose—especially on one side—you’ve experienced what reduced nasal patency can feel like. In plain language, nasal patency means how open your nasal passages are and how easily air can move through them. When that openness is reduced, symptoms often show up as chronic congestion, one-sided blockage, mouth breathing, exercise intolerance, and poor sleep.
For many people, the underlying problem isn’t just a “stuffy nose”—it’s a structural nasal obstruction, often related to a deviated septum or crowding inside the nasal passage. Septoplasty (surgery to straighten the septum) is widely performed in the U.S., which underscores how many patients ultimately explore procedural options for breathing relief. This article explains common reasons nasal patency is reduced, how the ClearPath nasal balloon system is designed to help, and what current evidence shows so far. For an overview of the approach itself, see balloon-assisted septoplasty: https://www.clearpathnasal.com/blog/what-is-balloon-assisted-septoplasty.
What causes reduced nasal patency? (Common structural reasons)
Structural problems are a bit like a doorway that’s partially blocked: even if the “air” around it is clean and calm (no allergies, no infection), the opening itself may still be too narrow for comfortable flow.
Deviated septum (septal deviation)
Your nasal septum is the wall that divides the left and right nasal passages. With a septal deviation, the septum is displaced off-center. That shift can narrow one side of the nose, disrupt normal airflow patterns, and create a “bottleneck” that makes breathing feel uneven—especially during sleep or exercise. Patients often describe it simply: “One nostril always feels like it’s doing all the work,” which can be more noticeable at night or during exertion.
Inferior turbinate enlargement and crowding in the nasal passage
Turbinates are normal internal structures that help warm and humidify air. But they can become enlarged (turbinate hypertrophy) or pushed inward, taking up more space in the nasal passage. When the septum is deviated, turbinates may also contribute to crowding—making nasal airflow feel restricted even if inflammation is controlled. If your septum is like the center divider in a hallway, and turbinates are like shelves along the wall, a shift in the divider plus slightly “bulkier” shelves can significantly narrow the walking path.
When it’s not “allergies”
Allergies and inflammation can absolutely cause congestion, but structural narrowing behaves differently. If sprays and allergy management reduce swelling yet you still feel persistent blockage—especially on one side—there may be an anatomic reason sprays can’t fully solve. In those cases, treating inflammation helps, but it may not restore normal openness if the airway is physically constrained. That’s one reason an ENT evaluation can be so useful—because the next step depends on what is narrowing the airway.
Conclusion: Structural narrowing—often from septal deviation and turbinate crowding—can limit nasal patency even when inflammation is treated.
Traditional septoplasty vs. ClearPath’s approach (high-level comparison)
There isn’t one “right” way to address nasal obstruction for every patient. Options depend on anatomy, symptom severity, medical history, and clinician judgment.
What traditional septoplasty often involves
When patients discuss conventional septoplasty with their clinician, the conversation often includes steps such as lifting the septal lining (flap elevation), reshaping or removing portions of cartilage/bone, and sometimes using packing, splints, and sutures. As with any procedure, risks can be part of the informed-consent discussion; commonly cited risks include septal perforation, hematoma, and scar bands (synechia). [1] Many patients do well with traditional approaches, particularly when deviation is complex. The key point is that traditional septoplasty often relies on direct surgical manipulation of cartilage and bone to create more space.
ClearPath’s goal: improve airflow while limiting tissue trauma
ClearPath is designed around a different concept: mechanically widening the nasal passage and mobilizing septal displacement using a controlled balloon catheter approach, rather than relying on extensive cutting or removal of cartilage. The intent is to improve breathing space while limiting tissue disruption described in more traditional techniques. [2] For an approach overview, see balloon-assisted septoplasty: https://www.clearpathnasal.com/blog/what-is-balloon-assisted-septoplasty.
Conclusion: Traditional septoplasty reshapes tissue directly; ClearPath is designed to widen space and mobilize the septum with a controlled balloon-based technique.
How ClearPath is designed to improve nasal airflow (patient-friendly steps)
A useful way to think about the device-based approach is “creating room and guiding alignment,” rather than “removing material.” The goal is still the same: a more open path for airflow.
Mechanically widening the nasal passage to create more breathing room
ClearPath is designed to expand intranasal space by displacing the inferior turbinate and the lower septum, creating a wider pathway for air to move through the nose. By increasing space in the passage, the goal is improved breathing comfort and function. [2] For a visual walkthrough, see how the ClearPath nasal balloon works: https://www.clearpathnasal.com/blog/how-the-clearpath-nasal-balloon-works-a-step-by-step-guide.
Hydrostatic pressure: mobilizing the septum without routine cartilage excision
One of the key ideas behind ClearPath is the use of hydrostatic, force-directed pressure. In simple terms, controlled pressure from the balloon is distributed across targeted areas to help mobilize and guide the septum toward a more midline position—without relying on cartilage excision as the primary mechanism. This is a “pressure-and-positioning” concept rather than a “remove-and-rebuild” concept. [2][3]
Why controlled, gradual inflation matters
ClearPath’s approach emphasizes gradual, controlled inflation. The practical goal of that control is precision: applying pressure in a predictable way, aiming to reduce unintended movement in nearby structures, and allowing the clinician to address tight areas step-by-step. [2]
Sequential dilation (from nasal floor toward the nasopharynx)
Not all obstruction occurs at a single point. ClearPath allows sequential dilation, meaning the clinician can address narrowing in stages along the length of the nasal airway—often moving from the nasal floor toward the back of the nose (nasopharynx). Think of it as opening a hallway segment-by-segment rather than forcing everything at once. [2]
Conclusion: ClearPath’s design centers on controlled, force-directed, stepwise dilation to create room and guide septal alignment.
Preserving mucosa: why it matters for comfort and recovery
Your nasal mucosa is the soft lining inside the nose. It helps regulate moisture, filtering, and overall function. When mucosa is irritated or injured, patients may experience more crusting, dryness, and discomfort during healing.
ClearPath is intended to preserve mucosal integrity by focusing on controlled dilation and mechanical widening, which may reduce the need for more aggressive tissue reduction in some cases (including more extensive turbinate tissue removal). [2] While every patient’s recovery is different, preserving mucosa is generally aligned with a smoother healing experience—without guaranteeing a specific outcome. Individual variability matters: anatomy, baseline inflammation, and healing responses differ.
Conclusion: A tissue-preserving strategy may support comfort during recovery, though individual experiences vary.
What the evidence shows so far (objective measures and symptom change)
When evaluating a nasal procedure—especially a newer technique—two questions tend to come up: Is it safe? and Does it measurably improve obstruction? Early evidence can be encouraging while still needing larger, longer-term studies.
Safety and complications reported in a retrospective series
In a retrospective analysis of 107 consecutive cases, the authors reported no major complications in this series, including no perforation, hematoma, mucosal injury, infection, synechia, or conversion to traditional septoplasty. [3] These findings are limited by the retrospective design, single-technique experience, and variable follow-up; absence of events in 107 cases does not establish zero risk. Results may not generalize to all settings or anatomies.
CT scan alignment improvements (objective anatomy changes)
In a subset of 23 patients with paired CT scans, septal symmetry improved 22% at the nasolacrimal duct (NLD) and 45% at the point of maximal deviation (PMD) (p = 0.005). Seventy-eight percent achieved at least a 30% improvement, and no patient worsened in this CT subset. [3] Objective imaging can help show what changed anatomically; for background on imaging, see CT scans to diagnose nasal blockages: https://www.clearpathnasal.com/blog/how-we-use-ct-scans-to-diagnose-nasal-blockages.
Patient-reported breathing and quality-of-life changes (SNOT-22)
In patients who completed the SNOT-22 questionnaire (n = 43), mean scores improved from 58.7 to 44.8—an approximate 23.8% reduction at one month (p = 0.02), with notable improvements in congestion, facial pressure/headache, and sleep quality. [3] Because these are short-term outcomes in a subset, they do not by themselves establish long-term durability. To learn what this score measures, see the SNOT-22 score: https://www.clearpathnasal.com/blog/the-snot-22-score-measuring-your-sinus-health.
Manufacturer-reported data point
ClearPath product documentation reports a 37% reduction in maximal septal deviation. [2] The excerpted materials do not include full study methods or follow-up, so this manufacturer-reported figure is supportive context rather than standalone clinical proof.
Conclusion: Early reports show encouraging safety signals and short-term anatomical and symptom improvements, but larger, longer-term studies are needed.
Who might be evaluated for a balloon-based approach?
A balloon-based approach is generally discussed in the context of structural narrowing. The goal is to match the technique to the anatomy—rather than forcing one solution for every type of obstruction.
Signs your reduced patency could be structural
- One-sided blockage that’s consistently worse on the same side
- Persistent congestion despite appropriate sprays/medical therapy
- Trouble breathing through the nose during exercise
- Snoring, mouth breathing, or waking up with dry mouth
These patterns don’t diagnose a deviated septum on their own, but they can be clues. In practice, they often prompt a closer look at internal anatomy rather than only adjusting medications.
Why imaging and exam matter
An ENT exam helps identify whether obstruction is driven mainly by septal deviation, turbinate hypertrophy, nasal valve issues, or a combination. Sometimes a CT scan is used to understand anatomy more clearly—especially when symptoms, exam findings, and treatment planning need additional confirmation. For more on imaging, see CT imaging for septal alignment: https://www.clearpathnasal.com/blog/how-we-use-ct-scans-to-diagnose-nasal-blockages. This workup helps set realistic expectations: if a patient’s main issue is outside the areas being widened, a different or additional approach may be needed.
Conclusion: Clinician evaluation—including exam and, when appropriate, CT imaging—guides whether a balloon-based strategy fits your anatomy.
What to expect (high-level) if your clinician recommends ClearPath
Many patients feel more comfortable moving forward once they understand the “why” and the “how.” These are general steps; your clinician’s process and recommendations will vary.
Before the procedure
Patients typically have an evaluation, discussion of goals, and a review of medical history and contributing factors (like prior nasal trauma, sinus symptoms, or inflammation). This is also where you can ask whether a minimally invasive septoplasty approach makes sense for your anatomy. A practical question to bring is: “Based on my exam and/or imaging, what specifically is narrowing my airway?”
During the procedure (simple overview)
At a high level, the ClearPath device is positioned in the nasal passage and then used for controlled balloon dilation according to the clinician’s plan (including sequential dilation where appropriate). [2][3] The procedure is designed to create space and improve alignment through controlled, force-directed dilation—not through cartilage excision as the primary mechanism. [2][3]
After the procedure and recovery basics
Afterward, patients generally monitor for short-term issues such as temporary congestion and mild bleeding, and they’ll have follow-up visits to assess healing and breathing. Your clinician will provide individualized guidance based on your anatomy and treatment plan. If you’re comparing options, it’s reasonable to ask how recovery expectations differ between a balloon-based approach and more traditional septoplasty steps.
Conclusion: The process centers on individualized planning, controlled dilation during the procedure, and clinician-guided follow-up.
FAQs about nasal patency and ClearPath
Is “nasal patency” the same as “nasal valve collapse”?
Not exactly. Nasal patency is the overall openness of the nasal airway. The nasal valve is a specific narrow region that can be a major limiting point. Valve narrowing can reduce patency, but patency can also be reduced by septal deviation and turbinate crowding deeper in the passage.
Will ClearPath replace traditional septoplasty?
Not for everyone. Anatomy, deviation severity, prior nasal history, and clinician judgment all matter. Current published outcomes support ClearPath as an option in appropriate patients, while also reinforcing the need for ongoing study. [3] A balanced way to view it is as an alternative that may be a fit for certain structural patterns—rather than a blanket replacement.
Can a deviated septum come back?
Nasal structures can shift with healing, scarring, ongoing inflammation, or future trauma, and results can vary from person to person. If you’re concerned about durability, ask your clinician how your specific septal deviation pattern may influence longer-term stability.
Conclusion: ClearPath is one option among several; the right approach depends on individualized anatomy and goals.
Conclusion: A tissue-preserving strategy to open the nasal airway
ClearPath is a device designed to improve nasal patency by widening the nasal passage and mobilizing septal displacement using controlled, sequential balloon dilation and hydrostatic, force-directed pressure. [2][3] Early evidence includes objective CT alignment improvements and short-term patient-reported symptom changes, with encouraging safety findings in a retrospective series. [3] Larger prospective studies with longer follow-up will be helpful to further clarify outcomes across patient types. [3]
If you’re dealing with persistent nasal obstruction—especially one-sided blockage that doesn’t respond to sprays—consider scheduling an evaluation with your local ENT. Ask whether a balloon-based approach like ClearPath could be appropriate for your anatomy, or whether a more traditional procedure would better match your needs.
Conclusion: Discuss your symptoms, anatomy, and goals with a qualified clinician to decide which option best fits you.
References
[1] Dillard et al. Rhinology Online. 2026.
[2] ClearPath Nasal Balloon System Playbook — Intuit Medical Products LLC, January 2025.
[3] Dillard J, Koudouovoh C, Lee V, Barnes C, Su R, Fortson JK. Outcomes of force-directed balloon-assisted endoscopic septoplasty: a retrospective analysis with a new technique and device. Rhinology Online. 2026;9:18–23.
Medical disclaimer
This article is for educational purposes only and is not medical advice. Please consult a qualified healthcare provider for diagnosis and treatment. It does not diagnose, treat, or replace evaluation by a qualified clinician. Talk with a licensed ENT or healthcare professional about symptoms, options, risks, and whether any procedure—including ClearPath or traditional septoplasty—is appropriate for you.








